| |
| |
| |
| » |
Preclinical Studies Home |
| --------------------------- |
| » |
PHY906 |
| |
|
| |
|
| |
|
| |
|
| » |
|
| ------------------------------ |
| » |
|
| ------------------------------ |
|
|
| |
| |
| |
| PHY906 |
| |
| PHY906, PhytoCeutica’s lead product, is a 4-herb traditional Chinese medicine (TCM) formulation with a history of more than 1800 years of human use. Each of PHY906’s 4 component herbs possess a distinct pharmacological profile, including anticancer and antiviral activity, hematological and immunological stimulation, analgesic activity, liver protection, and appetite improvement. Together, PHY906 has historically been used to treat diarrhea, abdominal spasms, fever, headache, vomiting, nausea, extreme thirst, and subcardial distention. Many of these ailments are also toxicities resulting from chemotherapeutic treatment. |
| |
| n exploring the application of PHY906 in the alleviation of chemotherapy-induced side effects, PhytoCeutica further developed PHY906 into a broad-spectrum adjuvant for conventional cancer chemotherapy, specifically in the areas of colorectal, liver, and pancreatic cancers. The molecular mechanisms that appear to contribute to PHY906’s pharmacological activity include inhibition of MMP-2, MDR, NFkB, ß-glucuronidase, the NK-1 receptor, and the delta-opioid receptor. |
| |
PHY906 is manufactured under GMP and all clinical batches have been evaluated for product consistency with PhytomicsQC™. PHY906 is also in clinical trials under an FDA IND. |
| |
| PhytoCeutica is currently actively pursuing partnerships to develop all aspects of PHY906 both in the U.S. and in Asia. |
| |
| PHY906 Preclinical Scientific Abstracts |
|
